Global Continuous Glucose Monitoring
Market Report
2025
Continuous Glucose Monitoring Market Report 2025 (Global Edition)
The global continuous glucose monitoring market size will be USD 4751.6 million in 2025. Increasing incidence of diabetes is expected to boost sales to USD 8794.8 million by 2033, with a Compound Annual Growth Rate (CAGR) of 8.00% from 2025 to 2033.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Continuous Glucose Monitoring Market Report 2025.
Global Continuous Glucose Monitoring Market Report 2025 Market Size Split by Device/Brand Outlook: (Guardian Real-Time CGM System, Dexcom Seven Plus, Dexcom G4 Platinum, FreeStyle Navigator, MiniMed P...
According to Cognitive Market Research, the global Continuous glucose monitoring market size will be USD 4751.6 million in 2025. It will expand at a compound annual growth rate (CAGR) of 8.00% from 2025 to 2033.
- North America held the major market share for more than 40% of the global revenue with a market size of USD 1758.09 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2033.
- Europe accounted for a market share of over 30% of the global revenue with a market size of USD 1377.96 million.
- APAC held a market share of around 23% of the global revenue with a market size of USD 1140.38 million in 2025 and will grow at a compound annual growth rate (CAGR) of 10.8% from 2025 to 2033.
- South America has a market share of more than 5% of the global revenue with a market size of USD 180.56 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2033.
- The Middle East had a market share of around 2% of the global revenue and was estimated at a market size of USD 190.06 million in 2025 and will grow at a compound annual growth rate (CAGR) of 9.3% from 2025 to 2033.
- Africa had a market share of around 1% of the global revenue and was estimated at a market size of USD 104.54 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2033.
- Dexcom G4 Platinum is the fastest growing category of the Continuous glucose monitoring industry
| 2024 | 2025 | 2032 | 2033 | CAGR | |
|---|---|---|---|---|---|
| Global Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 4751.6 Million | 121212 | $ 8794.8 Million | 8% |
| North America Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 1758.09 Million | 121212 | $ 2902.3 Million | 7% |
| United States Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 1387.13 Million | 121212 | 121212 | 6.3% |
| Mexico Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 159.99 Million | 121212 | 121212 | 7% |
| Canada Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 210.97 Million | 121212 | 121212 | 7.3% |
| Europe Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 426.88 Million | 121212 | $ 2374.6 Million | 7% |
| Denmark Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 28.94 Million | 121212 | 121212 | 6.8% |
| Germany Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 272.84 Million | 121212 | 121212 | 7.2% |
| Sweden Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 42.72 Million | 121212 | 121212 | 7.1% |
| France Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 126.77 Million | 121212 | 121212 | 6.2% |
| Luxembourg Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 16.54 Million | 121212 | 121212 | 7.3% |
| Spain Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 112.99 Million | 121212 | 121212 | 6.1% |
| United Kingdom Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 231.5 Million | 121212 | 121212 | 7.8% |
| Russia Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 213.58 Million | 121212 | 121212 | 6% |
| Switzerland Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 20.67 Million | 121212 | 121212 | 6.7% |
| Italy Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 118.5 Million | 121212 | 121212 | 6.4% |
| Rest of Europe Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 192.91 Million | 121212 | 121212 | 5.7% |
| Asia Pacific Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 1140.38 Million | 121212 | $ 2581.3 Million | 10.8% |
| Japan Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 157.37 Million | 121212 | 121212 | 9.3% |
| Singapore Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 22.81 Million | 121212 | 121212 | 11.1% |
| China Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 478.96 Million | 121212 | 121212 | 10.3% |
| Australia Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 59.3 Million | 121212 | 121212 | 10.1% |
| South East Asia Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 75.27 Million | 121212 | 121212 | 11.6% |
| India Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 114.04 Million | 121212 | 121212 | 12.7% |
| Taiwan Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 44.47 Million | 121212 | 121212 | 10.6% |
| South Korea Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 136.85 Million | 121212 | 121212 | 9.9% |
| Rest of APAC Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 51.32 Million | 121212 | 121212 | 10.6% |
| South America Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 180.56 Million | 121212 | $ 351.8 Million | 8.7% |
| Brazil Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 77.28 Million | 121212 | 121212 | 9.3% |
| Chile Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 13 Million | 121212 | 121212 | 9% |
| Peru Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 14.81 Million | 121212 | 121212 | 8.9% |
| Colombia Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 16.07 Million | 121212 | 121212 | 8.5% |
| Argentina Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 30.33 Million | 121212 | 121212 | 9.6% |
| Rest of South America Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 29.07 Million | 121212 | 121212 | 7.8% |
| Middle East Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 190.06 Million | 121212 | $ 387 Million | 9.3% |
| Qatar Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 15.21 Million | 121212 | 121212 | 8.8% |
| Saudi Arabia Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 66.9 Million | 121212 | 121212 | 9.6% |
| Egypt Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 11.4 Million | 121212 | 121212 | 9.1% |
| UAE Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 39.15 Million | 121212 | 121212 | 9.8% |
| Turkey Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 15.21 Million | 121212 | 121212 | 9.9% |
| Rest of Middle East Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 42.19 Million | 121212 | 121212 | 8.5% |
| Africa Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 190.06 Million | 121212 | $ 387 Million | 9.3% |
| South Africa Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 36.8 Million | 121212 | 121212 | 9.2% |
| Nigeria Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 8.36 Million | 121212 | 121212 | 8.5% |
| Rest of Africa Continuous Glucose Monitoring Market Sales Revenue | 121212 | $ 59.38 Million | 121212 | 121212 | 7.5% |
| Base Year | 2024 |
| Historical Data Time Period | 2021-2024 |
| Forecast Period | 2025-2033 |
| Market Split by Device/Brand Outlook: |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
| |
Report scope is customizable as we have a huge database of Continuous Glucose Monitoring industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Continuous Glucose Monitoring Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Continuous Glucose Monitoring Market Report Description
Introduction of the Continuous glucose monitoring Market
Continuous glucose monitoring systems (CGMs) are medical devices that detect and track glucose levels in real-time throughout the day and night. These systems typically include a small sensor inserted just beneath the skin that measures glucose levels every few minutes. This transmitter sends the data to a display device and a display device for interpreting the data. CGMs help people with diabetes and other conditions monitor their glucose levels and adjust their insulin or medication as needed. They can also detect patterns in glucose levels and alert users to potential problems earlier. The continuous glucose monitoring market benefits from growth and innovations in the medical device industry, which manufactures continuous glucose monitoring systems. The continuous glucose monitoring systems market is growing due to an increase in the number of companies developing continuous glucose monitoring systems
In September 2022, GlucoRx, a UK-based medical technology company, and Cardiff University announced the development of the world's first multi-sensor non-invasive continuous glucose monitoring system. It measures blood glucose levels every minute using radiofrequency technology and a multisensory approach that is both accurate and non-invasive. https://www.glucorx.co.uk/glucorx-announces-worlds-first-multi-sensor-non-invasive-glucose-monitoring/
Continuous Glucose Monitoring Market Size
Market Dynamics of Continuous glucose monitoring Market
Key Drivers for Continuous glucose monitoring Market
Increasing Incidence Of Diabetes Boost Market Growth
The rising prevalence of diabetes will drive market expansion. Chronic diabetes is caused by either insufficient insulin production by the pancreas or the body's inability to use the insulin it produces. According to the International Diabetes Federation's (IDF) Diabetes Atlas Tenth Edition 2021, diabetes affects approximately 537 million adults aged 20 to 79 years. By 2030, there will be 643 million diabetics in the world and 783 million by 2045. Nearly one in every two (240 million) adults with diabetes go undiagnosed, with three out of four living in low- and middle-income countries. Diabetes killed 6.7 million people and cost the healthcare system at least $966 billion, or 9% of total adult spending. Type 1 diabetes affects more than 1.2 million children and adolescents aged 0 to 19. Diabetes affects one of every six live births (21 million). Five hundred forty-one million adults are at higher risk of developing type II diabetes. As a result, the increasing prevalence of diabetes will drive market growth
https://idf.org/about-diabetes/diabetes-facts-figures/
Healthcare Infrastructure Development Drives Market Growth
The growth of healthcare infrastructure and rising healthcare expenditures contribute to the advancement of the market. In developed countries, the average yearly healthcare costs associated with diabetes are about $16,752 per individual. Research has indicated that the adoption of continuous glucose monitoring (CGM) systems can lead to a 25% reduction in hospital admissions and a 30% decrease in emergency room visits among consistent users, highlighting the considerable cost-saving opportunities in managing diabetes. For example, in 2023, UnitedHealthcare, a prominent health insurance provider in the U.S., started offering coverage for continuous glucose monitors for individuals with type 2 diabetes who need insulin, thereby making this technology more accessible to a wider range of patients.
Restraint Factor for the Continuous glucose monitoring Market
High Cost Related to Devices, Will Limit Market Growth
The high cost of continuous glucose monitoring systems is likely to have a negative impact on the market's early development. In developing countries such as India, patients bear the cost of blood glucose monitors and testing strips. Continuous glucose monitors are more expensive than finger-prick blood glucose testing; on average, a starter kit with replaceable sensors costs $1,000. Some CGM systems can cost several thousand dollars annually. The Dexcom G6, a popular CGM, has an average annual retail price of around $6,000, or $500 per month
Market Trends in Continuous glucose monitoring Market
New product launches are a major factor driving the growth of the continuous glucose monitoring market
Major players in the continuous blood glucose monitoring market are focusing on developing new technological solutions to strengthen their position. For instance, Abbott announced in June 2022 that it is developing a new bio wearable that will continuously monitor glucose and ketone levels in a single sensor. The system has received breakthrough device designation from the United States Food and Drug Administration, which is intended to expedite the review of innovative technologies that can improve the lives of people suffering from life-threatening or irreversibly debilitating illnesses or conditions. The glucose-ketone sensor will be the same size as Abbott's FreeStyle Libre 3 sensor, the world's smallest and thinnest continuous glucose monitoring (CGM) sensor. It will be linked to Abbott's digital ecosystem, which includes personal and caregiver mobile apps as well as cloud-based data management software for healthcare professionals to monitor remotely. In September 2022, Infinovo, an innovative medical technology company based in the United States, will launch the Glunovo®p3 Real-Time Calibration-Free CGM System at the European Association for the Study of Diabetes (EASD), one of the world's largest academic conferences on diabetes. In many European countries, patients with type 1 and type 2 insulin-dependent diabetes can obtain Infinovo's CGM products on prescription
New Technology Development is helping to boost the continuous glucose monitoring market
Major players in the continuous blood glucose monitoring market are focusing on developing new technological solutions to strengthen their position. For instance, DexCom Inc, a US-based provider of real-time continuous glucose monitoring for people with diabetes, announced in October 2022 that the Dexcom G7 Continuous Glucose Monitoring (CGM) System is now available in the United Kingdom, Ireland, Germany, Austria, and Hong Kong for people with diabetes aged two and up. Dexcom G7 provides a powerful yet simple way for users to gain more control over their diabetes, allowing them to manage the disease more confidently every day. The low-profile, all-in-one wearable warms up faster than any other CGM on the market
We have various report editions of Continuous Glucose Monitoring Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Competitive Landscape of the Continuous Glucose Monitoring Market
The Continuous glucose monitoring market is highly competitive, characterised by the presence of several global and regional players offering a wide range of products. Key companies in the market, such as Novo Nordisk A/S, Senseonics, DexCom, Inc., and Abbott Laboratories, dominate through their extensive product portfolios, strong distribution networks, and focus on innovation.
In November 2022, Senseonics Holdings, Inc., a leading medical technology company, announced a collaboration with the Nurse Practitioner Group (NPG). The collaboration aims to increase patient access by offering at-home and in-home insertion options for the Eversense E3 Continuous Glucose Monitoring System (CGM). Senseonics intends to expand the initiative into other key markets across the United States in the future. https://www.senseonics.com/investor-relations/news-releases/2022/11-03-2022-120329402 In December 2022, the US Food and Drug Administration (FDA) approved Dexcom's Continuous Glucose Monitoring System G7. Dexcom G7 is the most accurate integrated continuous glucose monitoring (iCGM) system, and its approval will help the company gain a strong foothold in the market. https://investors.dexcom.com/news/news-details/2022/Dexcom-G7-Receives-FDA-Clearance-The-Most-Accurate-Continuous-Glucose-Monitoring-System-Cleared-in-the-U.S/default.aspx In January 2024, Medtronic plc announced that its MiniMed 780G system with Simplera Sync had received CE Mark approval. Simple Sync is a technology that improves the user experience by simplifying the two-step insertion process. In addition, this new sensor is half the size of its predecessors. The MiniMed 780G system with Simplera Sync sensor is expected to launch in Europe via a limited release in the spring of 2024, followed by a phased commercial launch in the summer of the same year. https://news.medtronic.com/2024-01-08-Medtronic-Diabetes-announces-worlds-first-approval-for-MiniMed-TM-780G-System-with-Simplera-Sync-TM-disposable,-all-in-one-sensor
Top Companies Market Share in Continuous Glucose Monitoring Industry: (In no particular order of Rank)
- GlySens Incorporated
- A. Menarini Diagnostics S.r.l
- Novo Nordisk A/S
- Senseonics
- DexCom
- Inc.
- Abbott Laboratories
- Johnson & Johnson
- Medtronic plc
- F. Hoffman-La Roche Ltd
- Ypsomed AG
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Regional Analysis of the Continuous glucose monitoring Market
Which Region Dominates the Continuous Glucose Monitoring Market in 2025?
According to Cognitive Market Research, North America currently dominates the Continuous glucose monitoring market, and the region is expected to have significant growth during the projected period. Some of the factors contributing to market growth include rising diabetes prevalence, increased adoption of CGM devices, technological advancements, and the presence of key companies. Additionally, the federal government's efforts to manage the disease on a larger scale are fueling market growth
Which Region is Expanding at the Fastest CAGR?
Asia-Pacific is expected to grow at the fastest rate over the forecast period. The presence of a continuous glucose monitoring systems industry in the region contributes to market growth. Furthermore, the growing geriatric population and advancements in continuous glucose monitoring systems are expected to drive the Asia-Pacific continuous glucose monitoring system market.
The current report Scope analyzes Continuous Glucose Monitoring Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Continuous Glucose Monitoring Market Share (%) by Region (2021-2033)
Continuous Glucose Monitoring Market Share (%) by Country
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
North America Continuous Glucose Monitoring
According to Cognitive Market Research, the global Continuous glucose monitoring market size was estimated at USD 43521.6 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 1758.09 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2033.
United State Continuous glucose monitoring market size is USD 1387.13 million in 2025
According to Cognitive Market Research, the US had a major share in the Continuous glucose monitoring market with a market size of USD 1387.13 million in 2025 and is projected to grow at a CAGR of 6.3% during the forecast period. The U.S. Market's large diabetic population and strong healthcare spending.
Canada Continuous glucose monitoring market size is USD 210.97 million in 2025
The Canadian Continuous glucose monitoring market had a market share of USD 210.97 million in 2025 and is projected to grow at a CAGR of 7.3% during the forecast period. Canada’s government initiatives and rising diabetes rates.
Mexico Continuous glucose monitoring market size is USD 159.99 million in 2025
The Mexico Continuous glucose monitoring market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 159.99 million in 2025..
Europe Continuous Glucose Monitoring
According to Cognitive Market Research, the global Continuous glucose monitoring market size was estimated at USD 4751.6 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 1377.96 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2033.
United Kingdom Continuous glucose monitoring market size is USD 231.50 million in 2025
The United Kingdom Continuous glucose monitoring market had a market share of USD 231.50 million in 2025 and is projected to grow at a CAGR of 7.8% during the forecast period. In the UK, Continuous glucose monitoring sales witnessed an upswing due to increased emphasis on personalized diabetes management.
France Continuous glucose monitoring market size is USD 136.85 million in 2025
The France Continuous glucose monitoring market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 136.85 million in 2025.
Germany Continuous glucose monitoring market size is USD 272.84 million in 2025
According to Cognitive Market Research, the German Continuous glucose monitoring market size was valued at USD 272.84 million in 2025 and is projected to grow at a CAGR of 7.2% during the forecast period. In Germany, increased collaborations between local institutions and CGM manufacturers
Italy Continuous glucose monitoring market size is USD 118.50 million in 2025
The Italy Continuous glucose monitoring market is projected to witness growth at a CAGR of 6.4% during the forecast period, with a market size of USD 118.50 million in 2025.
Russia Continuous glucose monitoring market size is USD 213.58 million in 2025
The Russia Continuous glucose monitoring market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 213.58 million in 2025
Spain Continuous glucose monitoring market size is USD 112.99 million in 2025
The Spain Continuous glucose monitoring market is projected to witness growth at a CAGR of 6.1% during the forecast period with a market size of USD 112.99 million in 2025
Sweden Continuous glucose monitoring market size is USD 42.72 million in 2025
The Sweden Continuous glucose monitoring market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 42.72 million in 2025.
Denmark Continuous glucose monitoring market size is USD 28.94 million in 2025
The Denmark Continuous glucose monitoring market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 28.94 million in 2025
Switzerland Continuous glucose monitoring market size is USD 20.67 million in 2025
The Switzerland Continuous glucose monitoring market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 20.67 million in 2025.
Luxembourg Continuous glucose monitoring market size is USD 16.54 million in 2025
The Luxembourg Continuous glucose monitoring market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 16.54 million in 2025.
Rest of Europe Continuous glucose monitoring market size is USD 192.91 million in 2025
The Rest of Europe's Continuous glucose monitoring market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 192.91 million in 2025.
Asia Pacific Continuous Glucose Monitoring
According to Cognitive Market Research, the global Continuous glucose monitoring market size was estimated at USD 4751.6 Million, out of which APAC held the market share of around 23% of the global revenue with a market size of USD 1140.38 million in 2025 and will grow at a compound annual growth rate (CAGR) of 10.8% from 2025 to 2033.
China Continuous glucose monitoring market size is USD 157.37 million in 2025
According to Cognitive Market Research, the China Continuous glucose monitoring market size was valued at USD 157.37 million in 2025 and is projected to grow at a CAGR of 9.5% during the forecast period. Continuous glucose monitoring surged in China due to rising adoption of CGM technology.
Japan Continuous glucose monitoring market size is USD 157.37 million in 2025
The Japan Continuous glucose monitoring market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 157.37million in 2025
South Korea Continuous glucose monitoring market size is USD 136.85 million in 2025
The South Korea Continuous glucose monitoring market had a market share of USD 136.85 million in 2025 and is projected to grow at a CAGR of 11.8% during the forecast period. India's improving healthcare infrastructure.
India Continuous glucose monitoring market size is USD 114.04 million in 2025
The Indian Continuous glucose monitoring market is projected to witness growth at a CAGR of 9.1% during the forecast period, with a market size of USD 114.04 million in 2025.
Australia Continuous glucose monitoring market size is USD 59.30 million in 2025
The Australian Continuous glucose monitoring market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 59.30 million in 2025.
Singapore Continuous glucose monitoring market size is USD 22.81 million in 2025
The Singapore Continuous glucose monitoring market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 22.81 million in 2025.
Taiwan Continuous glucose monitoring market size is USD 44.47 million in 2025
The Taiwan Continuous glucose monitoring market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 44.47 million in 2025.
South East Asia Continuous glucose monitoring market size is USD 75.27 million in 2025
The South East Asia Continuous glucose monitoring market is projected to witness growth at a CAGR of 11.0% during the forecast period, with a market size of USD 75.27 million in 2025.
Rest of APAC Continuous glucose monitoring market size is USD 51.32 million in 2025
The Rest of APAC Continuous glucose monitoring market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 51.32 million in 2025.
South America Continuous Glucose Monitoring
According to Cognitive Market Research, the global Continuous glucose monitoring market size was estimated at USD 4751.6 Million, out of which South America held the market share of around 5% of the global revenue with a market size of USD 180.56 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2033.
Brazil Continuous glucose monitoring market size is USD 77.28 million in 2025
According to Cognitive Market Research, the Brazil Continuous glucose monitoring market size was valued at USD 77.28 million in 2025 and is projected to grow at a CAGR of 9.3% during the forecast period. Continuous glucose monitoring flourished in Brazil due to growing diabetic population.
Argentina Continuous glucose monitoring market size is USD 30.33 million in 2025
Argentina's Continuous glucose monitoring market had a market share of USD 30.33 million in 2025 and is projected to grow at a CAGR of 9.6% during the forecast period. Argentina's increased awareness of advanced diabetes management tools.
Colombia Continuous glucose monitoring market size is USD 16.07 million in 2025
Colombia Continuous glucose monitoring market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 16.07 million in 2025
Peru Continuous glucose monitoring market size is USD 14.81 million in 2025
Peru Continuous glucose monitoring market is projected to witness growth at a CAGR of 8.9% during the forecast period, with a market size of USD 14.81 million in 2025.
Chile Continuous glucose monitoring market size is USD 13.00 million in 2025
Chile Continuous glucose monitoring market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 13.00 million in 2025
Rest of South America Continuous glucose monitoring market size is USD 29.07 million in 2025
The Rest of South America's Continuous glucose monitoring market is projected to witness growth at a CAGR of 7.8% during the forecast period, with a market size of USD 29.07 million in 2025.
Middle East Continuous Glucose Monitoring
According to Cognitive Market Research, the global Continuous glucose monitoring market size was estimated at USD 4751.6 Million, out of which the Middle East held the major market share of around 2% of the global revenue with a market size of USD 190.06 million in 2025 and will grow at a compound annual growth rate (CAGR) of 9.3% from 2025 to 2033..
Qatar Continuous glucose monitoring market size is USD 15.21 million in 2025
The Qatar Continuous glucose monitoring market is projected to witness growth at a CAGR of 8.8% during the forecast period, with a market size of USD 15.21 million in 2025. Continuous glucose monitoring sales flourish due to the growing emphasis on diabetes awareness and management.
Saudi Arabia Continuous glucose monitoring market size is USD 66.90 million in 2025
The Saudi Arabia Continuous glucose monitoring market is projected to witness growth at a CAGR of 9.6% during the forecast period, with a market size of USD 66.90 million in 2025.
Turkey Continuous glucose monitoring market size is USD 15.21 million in 2025
The Turkey Continuous glucose monitoring market is projected to witness growth at a CAGR of 9.9% during the forecast period, with a market size of USD 15.21 million in 2025. Continuous glucose monitoring sales flourished in Turkey due to high prevalence of diabetes
UAE Continuous glucose monitoring market size is USD 39.15 million in 2025
The UAE Continuous glucose monitoring market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD 39.15 million in 2025.
Egypt Continuous glucose monitoring market size is USD 11.40 million in 2025
The Egypt Continuous glucose monitoring market is projected to witness growth at a CAGR of 9.1% during the forecast period, with a market size of USD 11.40 million in 2025.
Rest of the Middle East Continuous glucose monitoring market size is USD 42.19 million in 2025
The Rest of the Middle East Continuous glucose monitoring market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 42.19 million in 2025
Africa Continuous Glucose Monitoring
According to Cognitive Market Research, the global Continuous glucose monitoring market size was estimated at USD 4751.6 Million, out of which the Africa held the major market share of around 2% of the global revenue with a market size of USD 104.54 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2033..
Nigeria Continuous glucose monitoring market size is USD 8.36 million in 2025
The Nigeria Continuous glucose monitoring market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 8.36 million in 2025. Continuous glucose monitoring sales flourish due to the increased population, urbanization.
South Africa Continuous glucose monitoring market size is USD 36.80 million in 2025
The South Africa Continuous glucose monitoring market is projected to witness growth at a CAGR of 9.2% during the forecast period, with a market size of USD 36.80 million in 2025.
Rest of Africa Continuous glucose monitoring market size is USD 59.38 million in 2025
The Rest of Africa Continuous glucose monitoring market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 59.38 million in 2025.
Continuous Glucose Monitoring Market Analysis
Global Continuous Glucose Monitoring Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Continuous Glucose Monitoring Industry growth. Continuous Glucose Monitoring market has been segmented with the help of its Device/Brand Outlook:, , and others. Continuous Glucose Monitoring market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global Continuous glucose monitoring Market?
Continuous glucose monitoring Market Device/Brand Segment Analysis
According to Cognitive Market Research, The Guardian Real Time CGM System dominates the Continuous Glucose Monitoring (CGM) market. It is highly rated for its cutting-edge features, precision, and compatibility with insulin delivery systems, which makes it a popular option among healthcare professionals and patients.
The most rapidly growing category is the Dexcom G4 Platinum. The device is gaining popularity because of its ease of use, mobile connectivity, and ability to share real-time data. With more patients seeking easy and efficient means of managing diabetes, the Dexcom G4 Platinum is likely to experience high growth in adoption
Continuous Glucose Monitoring Market Share (%) by Device/Brand Outlook: in 2021-2033
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Continuous Glucose Monitoring Industry. Request a Free Sample PDF!
Segment Analysis of Continuous Glucose Monitoring Market
This report analyzes revenue growth in the pharma and healthcare industry at global, regional, and national levels, highlighting trends and opportunities for each application. It explores how sectors like pharmaceuticals, therapy, and healthcare monitoring use innovations to address healthcare needs. Key factors include market size, revenue contributions, technological advancements (e.g., AI-driven diagnostics), and regulatory considerations. The report also covers the value chain, identifying key players and processes within the industry. For more information, please request a sample or contact our research team.
Some of the key of Continuous Glucose Monitoring are:
Continuous Glucose Monitoring Market Share (%) by in 2021-2033
2021
2025
2033
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Author's Detail
Manjiri KanhereSenior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Conclusion
- The global Continuous glucose monitoring market will expand significantly by 8.00% CAGR between 2025 and 2033.
- The Guardian Real Time CGM System leads the Continuous Glucose Monitoring (CGM) market. It is highly rated for its cutting-edge features, precision, and compatibility with insulin delivery systems, making it a popular choice for healthcare professionals and patients
Frequently Asked Questions (FAQs)
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Continuous Glucose Monitoring Market
Sources from Pharma & Healthcare Industry
- https://en.wikipedia.org/wiki/American_Society_for_Pharmacy_Law
- https://en.wikipedia.org/wiki/American_Society_of_Consultant_Pharmacists
- https://en.wikipedia.org/wiki/American_Society_of_Health-System_Pharmacists
- https://www.apsm-uk.com/
- https://en.wikipedia.org/wiki/Australasian_College_of_Pharmacy
- https://en.wikipedia.org/wiki/American_Association_of_Colleges_of_Pharmacy
- https://en.wikipedia.org/wiki/American_College_of_Clinical_Pharmacy
- https://en.wikipedia.org/wiki/American_Pharmacists_Association
- https://www.bio.org/
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Association
- https://en.wikipedia.org/wiki/Canadian_Society_of_Hospital_Pharmacists
- https://en.wikipedia.org/wiki/Chinese_Pharmaceutical_Association
- https://en.wikipedia.org/wiki/American_Association_of_Psychiatric_Pharmacists
- https://en.wikipedia.org/wiki/Danish_Association_of_Pharmaconomists
- https://en.wikipedia.org/wiki/EPhEU
- https://www.fda.gov/
- https://www.gmc-uk.org/
- https://www.ifpma.org/
- https://www.fip.org/
- https://en.wikipedia.org/wiki/International_Pharmaceutical_Students%27_Federation
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
- https://en.wikipedia.org/wiki/National_Pharmacy_Association
- https://en.wikipedia.org/wiki/Norwegian_Pharmacy_Association
- https://en.wikipedia.org/wiki/Canadian_Pharmacists_Journal#History
- https://en.wikipedia.org/wiki/Pakistan_Pharmacists_Association
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Mauritius
- https://en.wikipedia.org/wiki/Pharmaceutical_Group_of_the_European_Union
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Australia
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_New_Zealand
- https://en.wikipedia.org/wiki/Pharmaceutical_Society_of_Northern_Ireland
- https://en.wikipedia.org/wiki/Professional_Compounding_Centers_of_America
- https://en.wikipedia.org/wiki/Royal_Pharmaceutical_Society
- https://www.aaps.org/home
- https://www.bioindustry.org/
- https://www.controlledreleasesociety.org/
- https://www.efpia.eu/
- https://www.epemed.org/online/www/content/ENG/index.html
- https://icr-global.org/
- https://ispe.org/
- https://en.wikipedia.org/wiki/Pharmaceutical_Association_of_Israel
- https://www.phrma.org/
- https://en.wikipedia.org/wiki/The_Pharmacy_Guild_of_Australia
- https://en.wikipedia.org/wiki/The_Society_of_Hospital_Pharmacists_of_Australia
- https://en.wikipedia.org/wiki/Healthcare_industry
- https://www.pharma-iq.com/business-development/articles/top-50-pharmaceutical-blogs-and-publications
- https://www.pharmatimes.com/news
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967517/
- https://www.cbo.gov/publication/57126
- http://: https://www.who.int/tools/atc-ddd-toolkit/data
- https://www.oecd.org/els/health-systems/health-data.htm
- https://www.bls.gov/ooh/healthcare/home.htm
- https://data.worldbank.org/topic/8
- https://www.statnews.com/about/
- https://www.health.pa.gov/topics/HealthStatistics/Pages/health-statistics.aspx
- https://www.cdc.gov/nchs/index.htm
- https://www.aha.org/statistics/fast-facts-us-hospitals
- https://www.census.gov/library/publications/2021/demo/p60-274.html
- https://www.adb.org/what-we-do/sectors/health/main
Continuous Glucose Monitoring Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Device/Brand Outlook: | Guardian Real-Time CGM System, Dexcom Seven Plus, Dexcom G4 Platinum, FreeStyle Navigator, MiniMed Paradigm Revel/Veo System, Others |
| List of Competitors | GlySens Incorporated, A. Menarini Diagnostics S.r.l, Novo Nordisk A/S, Senseonics, DexCom, Inc., Abbott Laboratories, Johnson & Johnson, Medtronic plc, F. Hoffman-La Roche Ltd, Ypsomed AG |
This chapter will help you gain GLOBAL Market Analysis of Continuous Glucose Monitoring. Further deep in this chapter, you will be able to review Global Continuous Glucose Monitoring Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Continuous Glucose Monitoring Revenue Market Size, Trend Analysis 2021 - 2033
-
1.2 Global Continuous Glucose Monitoring Market Size By Regions 2021 - 2033
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Continuous Glucose Monitoring Revenue Market Size By Region
-
-
1.3 Global Continuous Glucose Monitoring Market Size By Device/Brand Outlook: 2021 - 2033
-
1.3.1 Guardian Real-Time CGM System Market Size
-
1.3.2 Dexcom Seven Plus Market Size
-
1.3.3 Dexcom G4 Platinum Market Size
-
1.3.4 FreeStyle Navigator Market Size
-
1.3.5 MiniMed Paradigm Revel/Veo System Market Size
-
1.3.6 Others Market Size
-
-
1.4 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.5 Executive Summary Global Market (2021 vs 2025 vs 2033)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.5.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
-
1.5.2 Global Market Revenue Split By Device/Brand Outlook:
-
1.5.3 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
This chapter will help you gain North America Market Analysis of Continuous Glucose Monitoring. Further deep in this chapter, you will be able to review North America Continuous Glucose Monitoring Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
-
2.1 North America Continuous Glucose Monitoring Market Size 2021 - 2033
-
2.1.1 North America Continuous Glucose Monitoring Market Size By Country 2021 - 2033
-
2.1.2 North America Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
2.1.2.1 North America Guardian Real-Time CGM System Market Size
-
2.1.2.2 North America Dexcom Seven Plus Market Size
-
2.1.2.3 North America Dexcom G4 Platinum Market Size
-
2.1.2.4 North America FreeStyle Navigator Market Size
-
2.1.2.5 North America MiniMed Paradigm Revel/Veo System Market Size
-
2.1.2.6 North America Others Market Size
-
-
-
2.2 United States Market Size 2021 - 2033
-
2.2.1 United States Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
2.3 Canada Market Size 2021 - 2033
-
2.3.1 Canada Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
2.4 Mexico Market Size 2021 - 2033
-
2.4.1 Mexico Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
This chapter will help you gain Europe Market Analysis of Continuous Glucose Monitoring. Further deep in this chapter, you will be able to review Europe Continuous Glucose Monitoring Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
-
3.1 Europe Continuous Glucose Monitoring Market Size 2021 - 2033
-
3.1.1 Europe Continuous Glucose Monitoring Market Size By Country 2021 - 2033
-
3.1.2 Europe Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
3.1.2.1 Europe Guardian Real-Time CGM System Market Size
-
3.1.2.2 Europe Dexcom Seven Plus Market Size
-
3.1.2.3 Europe Dexcom G4 Platinum Market Size
-
3.1.2.4 Europe FreeStyle Navigator Market Size
-
3.1.2.5 Europe MiniMed Paradigm Revel/Veo System Market Size
-
3.1.2.6 Europe Others Market Size
-
-
-
3.2 United Kingdom Market Size 2021 - 2033
-
3.2.1 United Kingdom Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
3.3 France Market Size 2021 - 2033
-
3.3.1 France Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
3.4 Germany Market Size 2021 - 2033
-
3.4.1 Germany Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
3.5 Italy Market Size 2021 - 2033
-
3.5.1 Italy Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
3.6 Russia Market Size 2021 - 2033
-
3.6.1 Russia Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
3.7 Spain Market Size 2021 - 2033
-
3.7.1 Spain Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
3.8 Sweden Market Size 2021 - 2033
-
3.8.1 Sweden Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
3.9 Denmark Market Size 2021 - 2033
-
3.9.1 Denmark Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
3.10 Switzerland Market Size 2021 - 2033
-
3.10.1 Switzerland Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
3.11 Luxembourg Market Size 2021 - 2033
-
3.11.1 Luxembourg Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
3.12 Rest of Europe Market Size 2021 - 2033
-
3.12.1 Rest of Europe Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
This chapter will help you gain Asia Pacific Market Analysis of Continuous Glucose Monitoring. Further deep in this chapter, you will be able to review Asia Pacific Continuous Glucose Monitoring Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Continuous Glucose Monitoring Market Size 2021 - 2033
-
4.1.1 Asia Pacific Continuous Glucose Monitoring Market Size By Country 2021 - 2033
-
4.1.2 Asia Pacific Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
4.1.2.1 Asia Pacific Guardian Real-Time CGM System Market Size
-
4.1.2.2 Asia Pacific Dexcom Seven Plus Market Size
-
4.1.2.3 Asia Pacific Dexcom G4 Platinum Market Size
-
4.1.2.4 Asia Pacific FreeStyle Navigator Market Size
-
4.1.2.5 Asia Pacific MiniMed Paradigm Revel/Veo System Market Size
-
4.1.2.6 Asia Pacific Others Market Size
-
-
-
4.2 China Continuous Glucose Monitoring Market Size 2021 - 2033
-
4.2.1 China Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
4.3 Japan Continuous Glucose Monitoring Market Size 2021 - 2033
-
4.3.1 Japan Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
4.4 South Korea Continuous Glucose Monitoring Market Size 2021 - 2033
-
4.4.1 South Korea Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
4.5 India Continuous Glucose Monitoring Market Size 2021 - 2033
-
4.5.1 India Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
4.6 Australia Continuous Glucose Monitoring Market Size 2021 - 2033
-
4.6.1 Australia Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
4.7 Singapore Continuous Glucose Monitoring Market Size 2021 - 2033
-
4.7.1 Singapore Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
4.8 Taiwan Continuous Glucose Monitoring Market Size 2021 - 2033
-
4.8.1 Taiwan Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
4.9 South East Asia Continuous Glucose Monitoring Market Size 2021 - 2033
-
4.9.1 South East Asia Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
4.10 Rest of APAC Continuous Glucose Monitoring Market Size 2021 - 2033
-
4.10.1 Rest of APAC Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
This chapter will help you gain South America Market Analysis of Continuous Glucose Monitoring. Further deep in this chapter, you will be able to review South America Continuous Glucose Monitoring Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
-
5.1 South America Continuous Glucose Monitoring Market Size 2021 - 2033
-
5.1.1 South America Continuous Glucose Monitoring Market Size By Country 2021 - 2033
-
5.1.2 South America Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
5.1.2.1 South America Guardian Real-Time CGM System Market Size
-
5.1.2.2 South America Dexcom Seven Plus Market Size
-
5.1.2.3 South America Dexcom G4 Platinum Market Size
-
5.1.2.4 South America FreeStyle Navigator Market Size
-
5.1.2.5 South America MiniMed Paradigm Revel/Veo System Market Size
-
5.1.2.6 South America Others Market Size
-
-
-
5.2 Brazil Continuous Glucose Monitoring Market Size 2021 - 2033
-
5.2.1 Brazil Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
5.3 Argentina Continuous Glucose Monitoring Market Size 2021 - 2033
-
5.3.1 Argentina Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
5.4 Colombia Continuous Glucose Monitoring Market Size 2021 - 2033
-
5.4.1 Colombia Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
5.5 Peru Continuous Glucose Monitoring Market Size 2021 - 2033
-
5.5.1 Peru Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
5.6 Chile Continuous Glucose Monitoring Market Size 2021 - 2033
-
5.6.1 Chile Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
5.7 Rest of South America Continuous Glucose Monitoring Market Size 2021 - 2033
-
5.7.1 Rest of South America Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
This chapter will help you gain Middle East Market Analysis of Continuous Glucose Monitoring. Further deep in this chapter, you will be able to review Middle East Continuous Glucose Monitoring Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
-
6.1 Middle East Continuous Glucose Monitoring Market Size 2021 - 2033
-
6.1.1 Middle East Continuous Glucose Monitoring Market Size By Country 2021 - 2033
-
6.1.2 Middle East Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
6.1.2.1 Middle East Guardian Real-Time CGM System Market Size
-
6.1.2.2 Middle East Dexcom Seven Plus Market Size
-
6.1.2.3 Middle East Dexcom G4 Platinum Market Size
-
6.1.2.4 Middle East FreeStyle Navigator Market Size
-
6.1.2.5 Middle East MiniMed Paradigm Revel/Veo System Market Size
-
6.1.2.6 Middle East Others Market Size
-
-
-
6.2 Saudi Arabia Continuous Glucose Monitoring Market Size 2021 - 2033
-
6.2.1 Saudi Arabia Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
6.3 Turkey Continuous Glucose Monitoring Market Size 2021 - 2033
-
6.3.1 Turkey Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
6.4 UAE Continuous Glucose Monitoring Market Size 2021 - 2033
-
6.4.1 UAE Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
6.5 Egypt Continuous Glucose Monitoring Market Size 2021 - 2033
-
6.5.1 Egypt Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
6.6 Qatar Continuous Glucose Monitoring Market Size 2021 - 2033
-
6.6.1 Qatar Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
6.7 Rest of Middle East Continuous Glucose Monitoring Market Size 2021 - 2033
-
6.7.1 Rest of Middle East Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
This chapter will help you gain Middle East Market Analysis of Continuous Glucose Monitoring. Further deep in this chapter, you will be able to review Middle East Continuous Glucose Monitoring Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
-
7.1 Africa Continuous Glucose Monitoring Market Size 2021 - 2033
-
7.1.1 Africa Continuous Glucose Monitoring Market Size By Country 2021 - 2033
-
7.1.2 Africa Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
7.1.2.1 Africa Guardian Real-Time CGM System Market Size
-
7.1.2.2 Africa Dexcom Seven Plus Market Size
-
7.1.2.3 Africa Dexcom G4 Platinum Market Size
-
7.1.2.4 Africa FreeStyle Navigator Market Size
-
7.1.2.5 Africa MiniMed Paradigm Revel/Veo System Market Size
-
7.1.2.6 Africa Others Market Size
-
-
-
7.2 Nigeria Continuous Glucose Monitoring Market Size 2021 - 2033
-
7.2.1 Nigeria Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
7.3 South Africa Continuous Glucose Monitoring Market Size 2021 - 2033
-
7.3.1 South Africa Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
-
7.4 Rest of Africa Continuous Glucose Monitoring Market Size 2021 - 2033
-
7.4.1 Rest of Africa Continuous Glucose Monitoring Market Size by Device/Brand Outlook: 2021 - 2033
-
This chapter provides an in-depth analysis of the market share among key competitors of Continuous Glucose Monitoring. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2024
-
8.1.2 Global Continuous Glucose Monitoring Market Revenue and Share by Key Players
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability) Sample Format
-
8.2.1 GlySens Incorporated
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 A. Menarini Diagnostics S.r.l
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Novo Nordisk A/S
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Senseonics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 DexCom
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Abbott Laboratories
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Johnson & Johnson
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Medtronic plc
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 F. Hoffman-La Roche Ltd
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 Ypsomed AG
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Restraints
-
9.3 Market Trends
-
9.4 Market Opportunity
-
9.5 Technological Road Map (Subject to Data Availability)
-
9.6 Product Life Cycle (Subject to Data Availability)
-
9.7 Consumer Preference Analysis
-
9.8 Market Attractiveness Analysis
-
9.9 PESTEL Analysis
-
9.9.1 Political Factors
-
9.9.2 Economic Factors
-
9.9.3 Social Factors
-
9.9.4 Technological Factors
-
9.9.5 Legal Factors
-
9.9.6 Environmental Factors
-
-
9.10 Industrial Chain Analysis (Subject to Data Availability)
-
9.10.1 Industry Chain Analysis
-
9.10.2 Manufacturing Cost Analysis
-
9.10.3 Supply Side Analysis
-
9.10.3.1 Raw Material Analysis
-
9.10.3.2 Raw Material Procurement Analysis
-
9.10.3.3 Raw Material Price Trend Analysis
-
-
-
9.11 Porter’s Five Forces Analysis
-
9.11.1 Bargaining Power of Suppliers
-
9.11.2 Bargaining Power of Buyers
-
9.11.3 Threat of New Entrants
-
9.11.4 Threat of Substitutes
-
9.11.5 Degree of Competition
-
-
9.12 Patent Analysis (Subject to Data Availability)
-
9.13 ESG Analysis
Segmentation Device/Brand Outlook: Analysis 2019 -2031, will provide market size split by Device/Brand Outlook:. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Device/Brand Outlook: Analysis 2021 - 2033
-
10.1 Guardian Real-Time CGM System
-
10.1.1 Global Continuous Glucose Monitoring Revenue Market Size and Share by Guardian Real-Time CGM System 2021 - 2033
-
-
10.2 Dexcom Seven Plus
-
10.2.1 Global Continuous Glucose Monitoring Revenue Market Size and Share by Dexcom Seven Plus 2021 - 2033
-
-
10.3 Dexcom G4 Platinum
-
10.3.1 Global Continuous Glucose Monitoring Revenue Market Size and Share by Dexcom G4 Platinum 2021 - 2033
-
-
10.4 FreeStyle Navigator
-
10.4.1 Global Continuous Glucose Monitoring Revenue Market Size and Share by FreeStyle Navigator 2021 - 2033
-
-
10.5 MiniMed Paradigm Revel/Veo System
-
10.5.1 Global Continuous Glucose Monitoring Revenue Market Size and Share by MiniMed Paradigm Revel/Veo System 2021 - 2033
-
-
10.6 Others
-
10.6.1 Global Continuous Glucose Monitoring Revenue Market Size and Share by Others 2021 - 2033
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Continuous Glucose Monitoring market
Chapter 11 Research Findings
-
11.1 Key Takeaways
-
11.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
11.3 Assumptions and Acronyms
Chapter 12 Research Methodology and Sources
-
12.1 Primary Data Collection
-
12.1.1 Steps for Primary Data Collection
-
12.1.1.1 Identification of KOL
-
-
12.1.2 Backward Integration
-
12.1.3 Forward Integration
-
12.1.4 How Primary Research Help Us
-
12.1.5 Modes of Primary Research
-
-
12.2 Secondary Research
-
12.2.1 How Secondary Research Help Us
-
12.2.2 Sources of Secondary Research
-
-
12.3 Data Validation
-
12.3.1 Data Triangulation
-
12.3.2 Top Down & Bottom Up Approach
-
12.3.3 Cross check KOL Responses with Secondary Data
-
-
12.4 Data Representation
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Manjiri Kanhere and Team
- 1 Data Gathering
- 1.1 Primary Research
- 1.1.1 Steps for Primary Data Collection
- 1.1.1.1 Identification of KOL
- 1.1.1.2 Backward Integration
- 1.1.1.3 Forward Integration
- 1.1.1.4 How Primary Research Help Us
- 1.1.1.5 Modes of Primary Research
- 1.1.1 Steps for Primary Data Collection
- 1.2 Secondary Research
- 1.2.1 How Secondary Research Help Us
- 1.2.2 Sources of Secondary Research
- 1.1 Primary Research
- 2 Data Validation
- 2.1 Cross check KOL Responses with Secondary Data
- 2.2 Top Down & Bottom Up Approach
- 2.3 Data Triangulation
- 3 Data Representation
Key Questions Answered By Continuous Glucose Monitoring Market Report 2025
| Why Guardian Real-Time CGM System have a significant impact on Continuous Glucose Monitoring market? |
| What are the key factors affecting the Guardian Real-Time CGM System and Dexcom Seven Plus of Continuous Glucose Monitoring Market? |
| What is the CAGR/Growth Rate of during the forecast period? |
| By type, which segment accounted for largest share of the global Continuous Glucose Monitoring Market? |
| Which region is expected to dominate the global Continuous Glucose Monitoring Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
